These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9743444)

  • 1. Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release.
    Veronese FM; Marsilio F; Caliceti P; De Filippis P; Giunchedi P; Lora S
    J Control Release; 1998 Mar; 52(3):227-37. PubMed ID: 9743444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterisation of polyphosphazene-based controlled release systems for naproxen.
    Caliceti P; Lora S; Marsilio F; Veronese FM
    Farmaco; 1995 Dec; 50(12):867-74. PubMed ID: 8634078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method.
    Obeidat WM; Price JC
    J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems.
    Conforti A; Bertani S; Lussignoli S; Grigolini L; Terzi M; Lora S; Caliceti P; Marsilio F; Veronese FM
    J Pharm Pharmacol; 1996 May; 48(5):468-73. PubMed ID: 8799869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tabletted polylactide microspheres prepared by a w/o emulsion-spray drying method.
    Giunchedi P; Gavini E; Bonacucina G; Palmieri GF
    J Microencapsul; 2000; 17(6):711-20. PubMed ID: 11063418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation and intra-articular administration of biodegradable microspheres containing naproxen sodium.
    Bozdağ S; Caliş S; Kaş HS; Ercan MT; Peksoy I; Hincal AA
    J Microencapsul; 2001; 18(4):443-56. PubMed ID: 11428674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
    Yang YY; Chia HH; Chung TS
    J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics.
    Pistel KF; Bittner B; Koll H; Winter G; Kissel T
    J Control Release; 1999 Jun; 59(3):309-25. PubMed ID: 10332063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of microsphere solidification time in the solvent evaporation process.
    Mateović T; Ratnik M; Bogataj M; Mrhar A
    J Microencapsul; 2005 Feb; 22(1):81-90. PubMed ID: 16019893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphosphazene microspheres for insulin delivery.
    Caliceti P; Veronese FM; Lora S
    Int J Pharm; 2000 Dec; 211(1-2):57-65. PubMed ID: 11137339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs.
    Duarte AR; Costa MS; Simplício AL; Cardoso MM; Duarte CM
    Int J Pharm; 2006 Feb; 308(1-2):168-74. PubMed ID: 16368203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
    Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
    Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin loaded pH-sensitive microparticles.
    Meissner Y; Ubrich N; Ghazouani FE; Maincent P; Lamprecht A
    Int J Pharm; 2007 Apr; 335(1-2):147-153. PubMed ID: 17150317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.
    O'Hara P; Hickey AJ
    Pharm Res; 2000 Aug; 17(8):955-61. PubMed ID: 11028941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
    Atuah KN; Walter E; Merkle HP; Alpar HO
    J Microencapsul; 2003; 20(3):387-99. PubMed ID: 12881118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.